Literature DB >> 29887791

Axillary Web Syndrome in Breast Cancer: A Prevalent But Under-Recognized Postoperative Complication.

Susan R Harris1.   

Abstract

The purpose of this review is to define axillary web syndrome (AWS) and describe its diagnosis and management. The following databases were searched through July 2017: PubMed, EMBASE (OvidSP), Cumulative Index for Nursing and Allied Health Literature, Physiotherapy Evidence Database, and Cochrane Database of Systematic Reviews. Search terms included 'axillary web syndrome', 'axillary cording', and 'lymphatic cording'. 49 articles were identified; 8 did not relate to breast cancer, and 3 were not in English. Of the remaining articles, the majority were case reports, case series, or descriptive reviews. 2 systematic reviews were located as well as 1 randomized trial, 6 prospective cohort studies, and 2 retrospective cohort studies. Although a common sequela after axillary surgery for breast cancer staging, AWS has been poorly described in the medical literature as to the underlying pathophysiology, diagnosis, and management. Interventions range from patient education and simple reassurance that the syndrome will resolve spontaneously to active physical or manual therapies to maintain upper extremity range-of-motion, especially adequate motion for undergoing radiation therapy. Oncologists, breast surgeons, family physicians, and oncology nurse practitioners that work with patients with breast cancer should educate them about this prevalent complication and inform them preoperatively about what to anticipate.

Entities:  

Keywords:  Axillary web syndrome; Breast cancer; Lymphatic cording

Year:  2018        PMID: 29887791      PMCID: PMC5981636          DOI: 10.1159/000485023

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


  29 in total

1.  Movement, Function, Pain, and Postoperative Edema in Axillary Web Syndrome.

Authors:  Linda A Koehler; Anne H Blaes; Tuffia C Haddad; David W Hunter; Alan T Hirsch; Paula M Ludewig
Journal:  Phys Ther       Date:  2015-05-14

2.  Axillary web syndrome following sentinel node biopsy for breast cancer.

Authors:  S M Nieves Maldonado; V Pubul Núñez; S Argibay Vázquez; M Macías Cortiñas; Á Ruibal Morell
Journal:  Rev Esp Med Nucl Imagen Mol       Date:  2016-05-31       Impact factor: 1.359

3.  Incidence and risk factors for axillary web syndrome after breast cancer surgery.

Authors:  Anke Bergmann; Valéria Vasconcellos Mendes; Ricardo de Almeida Dias; Blenda do Amaral E Silva; Maria Giseli da Costa Leite Ferreira; Erica Alves Nogueira Fabro
Journal:  Breast Cancer Res Treat       Date:  2011-10-11       Impact factor: 4.872

4.  Axillary web syndrome is not a risk factor for lymphoedema after 10 years of follow-up.

Authors:  Bárbara Reis Wariss; Rejane Medeiros Costa; Ana Carolina Padula Ribeiro Pereira; Rosalina Jorge Koifman; Anke Bergmann
Journal:  Support Care Cancer       Date:  2016-10-04       Impact factor: 3.603

5.  Complication rates in patients with negative axillary nodes 10 years after local breast radiotherapy after either sentinel lymph node dissection or axillary clearance.

Authors:  A Gabriella Wernicke; Michael Shamis; Kulbir K Sidhu; Bruce C Turner; Yevgenyia Goltser; Imraan Khan; Paul J Christos; Lydia T Komarnicky-Kocher
Journal:  Am J Clin Oncol       Date:  2013-02       Impact factor: 2.339

6.  Risk factors of breast cancer-related lymphedema.

Authors:  Saadet Ugur; Cumhur Arıcı; Muhittin Yaprak; Ayhan Mescı; Gulbin Ayse Arıcı; Kemal Dolay; Vahit Ozmen
Journal:  Lymphat Res Biol       Date:  2013-06       Impact factor: 2.589

7.  Axillary Web Syndrome: Current Understanding and New Directions for Treatment.

Authors:  Merisa Piper; Isabella Guajardo; Keith Denkler; Hani Sbitany
Journal:  Ann Plast Surg       Date:  2016-05       Impact factor: 1.539

8.  Frequency and associated factors of axillary web syndrome in women who had undergone breast cancer surgery: a transversal and retrospective study.

Authors:  Kassandra Ferreira Pessoa Fukushima; Luana Aroucha Carmo; Adriana Carvalho Borinelli; Caroline Wanderley Souto Ferreira
Journal:  Springerplus       Date:  2015-03-05

9.  Axillary web syndrome following secondary breast-conserving surgery: a case report.

Authors:  Panmei Wei; Liling Zhu; Kai Chen; Weijuan Jia; Yue Hu; Fengxi Su
Journal:  World J Surg Oncol       Date:  2013-01-17       Impact factor: 2.754

10.  Effects of a physical therapy program combined with manual lymphatic drainage on shoulder function, quality of life, lymphedema incidence, and pain in breast cancer patients with axillary web syndrome following axillary dissection.

Authors:  Youngki Cho; Junghwa Do; Sunyoung Jung; Ohyun Kwon; Jae Yong Jeon
Journal:  Support Care Cancer       Date:  2015-11-05       Impact factor: 3.359

View more
  4 in total

1.  Axillary web syndrome among Chilean women with breast cancer: incidence and possible predisposing factors.

Authors:  Karol Ramírez-Parada; Diana Garay-Acevedo; Williams Mella-Abarca; Militza Petric-Guajardo; César Sánchez-Rojel; Margaret L McNeely; Ivana Leao-Ribeiro; Rodrigo Fernández-Verdejo
Journal:  Support Care Cancer       Date:  2019-11-25       Impact factor: 3.603

2.  Cording: a treatable complication of breast cancer surgery.

Authors:  Chani Smith
Journal:  Br J Gen Pract       Date:  2019-08       Impact factor: 5.386

Review 3.  Axillary Web Syndrome in Breast Cancer Women: What Is the Optimal Rehabilitation Strategy after Surgery? A Systematic Review.

Authors:  Lorenzo Lippi; Alessandro de Sire; Luigi Losco; Kamal Mezian; Arianna Folli; Mariia Ivanova; Lorenzo Zattoni; Stefano Moalli; Antonio Ammendolia; Carmine Alfano; Nicola Fusco; Marco Invernizzi
Journal:  J Clin Med       Date:  2022-07-01       Impact factor: 4.964

4.  Early Physical Rehabilitation after Sentinel Lymph Node Biopsy in Breast Cancer: Is It Feasible and Safe?

Authors:  Beatriz Ostos-Díaz; María Jesús Casuso-Holgado; María Jesús Muñoz-Fernández; Ana F Carazo; Rocío Martín-Valero; Esther M Medrano-Sánchez
Journal:  Int J Environ Res Public Health       Date:  2020-11-12       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.